A Bill On Monday, a House Subcommittee voted to approve the use of cannabis vaporized methods in Iowa’s medical marijuana program. Des Moines Register reports. Reports.
Rep. Hans Wilz’s (R) bill sponsor told The Register after the meeting that he wanted to “keep the proposal as narrow in scope” and that alternative things discussed by the Subcommittee were “placed in another place within legislation”.
Iowa’s medical cannabis program is among the most limited in the country and currently only allows tablets, capsules, liquids, tinctures, topicals like gels, ointments, creams, lotions, patches, and nebulizable and inhaled or vaporizable products, and suppositories.
Lucas Nelson, president of MedPharm Iowa, which owns and operates Bud & Mary’s Cannabis in the state – one of just two state-licensed medical cannabis manufacturers in Iowa – said that if the bill passes the company would commit to lowering costs for patients up to an estimated 50%.
The people will benefit from this reduction in costs. A patient from outside Ottumwa visits us. Her chronic pain is so severe that she cannot use her insurance, which doesn’t cover any medical cannabis. “And she specifically uses these products in order to be there for her grandson.” — Nelson via the Register
Iowa Medical Cannabidiol Advisory Board data shows that the number of patients using medical cannabis has decreased from 18230 in 2023, to just under 18,000 as of the end last year. Report 2024.
Another piece of legislation – Senate File 46 – passed a subcommittee last week. The bill seeks to increase the licenses of dispensaries to 10 from 5.
Subscribe to our daily Cannabis Business News Updates. Subscribe to our Newsletter
MEDACAN24 can only be made possible with the help of our partners.